D-0636-2024 Class II Ongoing

Recalled by Fagron Compounding Services — Wichita, KS

FDA drug recall D-0636-2024 was initiated by Fagron Compounding Services on Aug 15, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Aug 28, 2024
Initiation Date
Aug 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the USA

Code information

Lot#: C274-000037397, C274-000037398, C274-000037399, C274-000037400, Exp. Date 10/14/2024.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0636-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0636-2024. Report a data issue: hello@regdatalab.com.